Search

everythinglearnresearchcommunity

for

Search:↓

Patients with metabolic syndrome had lower Gleason scores when diagnosed with prostate cancer.

Surgery for high-risk prostate cancer is challenging but doesn't lead to more complications, and additional treatment is often needed.

A higher genetic risk score increases the chance of getting benign prostatic hyperplasia and affects treatment outcomes in Han Chinese men.

SRD5A1 is crucial in advanced prostate cancer, and blocking both SRD5A1 and SRD5A2 is more effective than targeting SRD5A2 alone.

A young man with high-grade prostate cancer had successful surgery and good recovery, highlighting the need for awareness in younger men.

CT scans can find serious prostate cancer even when PSA levels are low.

Finasteride reduces prostate cancer risk but may increase high-grade tumors and has side effects; biopsy methods have similar outcomes; psychosocial factors affect sexual recovery post-surgery.

Prostate-specific antigen may be a new marker for excess male hormones in women with polycystic ovary syndrome.

Women with PCOS have higher PSA levels, which are linked to increased male hormone levels and hirsutism.

Dihydrotestosterone gel improved well-being and sexual function in older men without negatively affecting prostate health.

5 alpha-reductase inhibitors can slightly improve symptoms of enlarged prostate but have a high risk of sexual side effects.

Early hair loss may indicate future prostate issues.

There's no link between hair loss type androgenic alopecia and benign prostatic hyperplasia, but early hair loss and family history can mean more severe alopecia.

Doxazosin alone or combined with finasteride improves prostate symptoms better than finasteride alone, without extra benefits.

Dutasteride is slightly better than finasteride for treating BPH but has fewer sexual side effects.

Cervi Parvum Cornu complex improved urinary symptoms in men without major side effects.

Early balding may be a sign of future prostate problems.

Early hair loss in men could be a sign of non-cancerous prostate enlargement, and treating hair loss early might help prevent prostate issues later.

Higher urethral PSA levels after prostate removal may be linked to more scalp hair loss and more PSA in urethral glands.

Finasteride therapy reduces PSA levels and prostate size, helping diagnose prostate cancer.

PSA testing is a reliable method for detecting prostate cancer, and opioids may lower PSA levels, but triglycerides don't affect prostate cancer risk.

Higher urethral PSA levels after prostate removal surgery may be linked to more hair loss and higher PSA levels post-surgery.

Baricitinib helps alopecia areata and may improve psoriasis, but its effect on psoriatic arthritis is unclear.

Baricitinib improves alopecia areata and may help psoriasis but might not be ideal for psoriatic arthritis.

IL-17 inhibitors are more effective than methotrexate in preventing psoriatic arthritis in psoriasis patients.

The document does not confirm if radical prostatectomy is the best treatment for locally advanced prostate cancer.

Finasteride improves urinary symptoms and quality of life in BPH patients, especially with larger prostate size.

Metformin may lower PSA levels, possibly affecting prostate cancer development.

Opioid use may lower PSA levels, suggesting a possible role in prostate cancer control; PSA testing is useful for detecting prostate cancer; serum triglycerides are not linked to prostate cancer risk; and higher urethral PSA levels may be associated with local hormone activity.

Pumpkin seed oil may improve prostate health, bladder control, and hair growth in men.